Great Valley Advisor Group, Inc. Bluebird Bio, Inc. Transaction History
Great Valley Advisor Group, Inc.
- $3.84 Billion
- Q3 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 12,000 shares of BLUE stock, worth $48,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,000
-0.0%
Holding current value
$48,960
Previous $11,000
45.45%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
19Shares Held
20.3MCall Options Held
0Put Options Held
2K-
Black Rock Inc. New York, NY15.4MShares$63 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$19 Million0.02% of portfolio
-
Colony Group LLC Boston, MA41.9KShares$171,1230.0% of portfolio
-
Connacht Asset Management LP New York, NY31.6KShares$129,0660.59% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL28.7KShares$117,1360.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $315M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...